Doxorubicin (DOX ) and other anthracyclines are commonly used in the treatment of cancer, both leukemias and solid tumors. The clinical use of these drugs is limited by side effects , especially the cardiotoxicity , myelosuppression , or damage to the kidneys . Efforts are therefore numerous studies aimed at reducing the side effects and increase the efficacy of doxorubicin and other anthracyclines . One alternative strategy is the use of drugs conveyors , such as liposomes, dendrimers , or the antibody nanoparticles .